Aker BioMarine ASA – Satisfaction of conditions for exercise of call option

Reference is made to the announcement published 16 March 2026 regarding Aker BioMarine ASA exercising its call option to redeem all outstanding bonds under its senior secured bond issue “FRN Senior Secured NOK 2,000,000,000 Bonds 2024/2027” (ISIN NO0013326025). The exercise of the call option was conditional on satisfaction of the conditions precedent for utilisation of a new credit facility agreement in an amount sufficient to redeem the outstanding bonds. We are pleased to confirm that the conditions have been satisfied and that all outstanding bonds will be redeemed as set out in announcement published 16 March 2026. The entire bond issue will be repaid at a price equal to 102.125% of the nominal amount for each redeemed bond plus accrued interest, with record date on 26 March 2026 and call option repayment date on 30 March 2026. The confirmation from Nordic Trustee AS to the bondholders is attached.

For any questions, please contact:

For further information, please contact Katrine Klaveness, CFO Mobile: +47 991 58 915 Email: Katrine.klaveness@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to MAR Article 19 and Section 5-12 of the Norwegian Securities Trading Act.

About Aker BioMarine: Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.